A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was ...

Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau.

The first participants in an international clinical trial aimed at preventing Alzheimer’s disease in young adults at high ...

Leqembi (lecanemab) and Kisunla (donanemab) are proven to slow cognitive and functional decline by 27 and 35%, respectively.

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...